Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,128 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07207408RecruitingPhase 2
Plague vaccine study for healthy adults
This study tests an experimental vaccine to protect against plague. It's for healthy adults 18 to 55 who haven't had plague or the vaccine before. The goal is to see if the vaccine is safe and creates a strong immune response.
Miami, FloridaAges 18–55 - NCT07622797RecruitingPhase 2
Immunotherapy with chemotherapy and radiation for esophageal cancer
This trial tests a new immunotherapy drug (camrelizumab) combined with standard chemotherapy and radiation to treat advanced esophageal cancer while avoiding surgery if possible. The goal is to shrink the tumor and help you keep your esophagus working.
Luoyang, HenanAges 18 years+ - NCT06860867Recruiting
Nucleus replacement for single-level discogenic low back pain
This trial tests a new device called PerQdisc for people with chronic low back pain from a single damaged disc in the lower spine. The goal is to see if the device can safely replace the inner gel of the disc without major surgery.
Glendale, ArizonaAges 22–70 - NCT07050537Recruiting
Oxygen levels for embryo growth in IVF treatment
This trial tests whether keeping embryos at a constant 5% oxygen is better than starting at 5% and lowering to 2% during IVF. It aims to find the best way to help your embryos develop and improve your chances of a successful pregnancy.
Zhengzhou, HenanAges 20–40 - NCT07029451Recruiting
Study of REKOVELLE for first-time IVF or ICSI in Chinese women
This study looks at how well the medication REKOVELLE works for Chinese women going through their first IVF or ICSI cycle. It will track real-world results, safety, and how the medication is used. It may help if you are starting IVF or ICSI for the first time.
Hefei, AnhuiAges 20 years+ - NCT06866028Recruiting
Brain training to improve emotion regulation using fNIRS feedback
This trial uses a brain imaging technique called fNIRS (a safe, non-invasive headband) to give you real-time feedback on your brain activity. The goal is to help you learn to improve your emotion regulation. It may be helpful if you have no major mental health conditions and want to try a new way to manage emotions.
Hong KongAges 18–30 - NCT05988931Recruiting
Text message program for teens who drink alcohol
This study tests a text message program to help teenagers reduce or stop their alcohol use. If you or your teen has had alcohol in the past year and has a phone that can receive texts, this may be a good fit.
Ann Arbor, MichiganAges 12–19 - NCT07005193Recruiting
Cleaner cooking and ventilation for better heart and lung health
This study tests if switching to cleaner LPG gas stoves and adding kitchen fans can reduce indoor air pollution and improve your heart and lung health. You would be asked to use a new stove and fan, and we will check your health over time.
Zhumadian, HenanAges 18–75 - NCT07741006Enrolling by invitationEarly Phase 1
PET imaging study for adults with solid tumors
This study tests a new PET imaging agent called [68Ga]Ga-ELI411 to help see tumors more clearly. It is for adults with solid tumors who are already scheduled for a standard PET scan, and may help doctors better understand and manage their cancer.
Wuhan, HubeiAges 18 years+ - NCT06742008Recruiting
Can antibodies predict heart damage after viral myocarditis?
This study looks at whether certain antibodies in your blood can predict if viral myocarditis will lead to a weakened heart muscle (dilated cardiomyopathy). It may help doctors understand your risk and plan better care.
Wuhan, HubeiAges 18–75 - NCT07309900RecruitingPhase 1
Testing IASO208 for relapsed or hard-to-treat B-cell cancers
This trial tests a new treatment called IASO208 for people with certain types of B-cell lymphoma that have come back or not responded to standard treatments. It aims to see if the drug can help shrink tumors and control the cancer.
Wuhan, HubeiAges 18–75 - NCT06994429Enrolling by invitation
New MRI to check liver function after transplant
This study uses a new MRI technique to check how well your new liver is working after transplant, without any needles or biopsy. If you have had a liver transplant and are scheduled for an MRI, you may be able to join.
Wuhan, HubeiAges 18–80 - NCT07611448Enrolling by invitation
AI Tool to Help Select the Best Embryo for Pregnancy
This study tests whether artificial intelligence can better identify which embryos are most likely to result in a successful pregnancy during fertility treatment. Researchers will use an AI system to analyze embryo images on days 5–7 of development to help doctors choose the best embryo to transfer.
Clovis, CaliforniaAges 18–45 - NCT06467110Enrolling by invitation
Study of SQ-Kyrin TMVr System for leaky mitral valve
This trial tests a new device called the SQ-Kyrin TMVr System to treat severe mitral regurgitation (a leaky heart valve) in people who are not good candidates for traditional open-heart surgery. The goal is to repair the valve without major surgery, using a catheter-based approach.
Shenyang, LiaoningAges 18 years+ - NCT07253116RecruitingPhase 1/Phase 2
Study of WJ22096 tablets for advanced solid tumors
This trial tests a new oral drug (WJ22096) for people with advanced solid tumors that have stopped responding to or cannot tolerate standard treatments. It may be an option if you are generally healthy enough to take part.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06953323RecruitingPhase 1/Phase 2
Study of WJB001 combined therapy for advanced solid tumors
This trial tests a new drug combination for people with advanced solid tumors that are no longer responding to standard treatments. It focuses on patients whose tumors have high levels of a protein called CCNE1, particularly for certain ovarian, fallopian tube, peritoneal, and uterine cancers.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05345418RecruitingPhase 1/Phase 2
Cord blood stem cell treatment for low male hormones
This trial tests whether umbilical cord stem cells can improve hormone-related sexual function in men with low testosterone and related symptoms. It’s an early-phase study, so the goal is to see safety and whether symptoms and hormone measures improve.
HanoiAges 50–70 - NCT06343714RecruitingPhase 1
Testing a new drug for knee osteoarthritis pain
This study tests a new antibody drug (FB1003) for people with knee osteoarthritis pain. It will check if the drug is safe and helps reduce pain. You may be eligible if you have moderate to severe knee pain and are willing to temporarily stop your usual pain medications.
Brisbane, QueenslandAges 18–75 - NCT06911489RecruitingPhase 1
Safety trial of a new targeted therapy for advanced solid tumors
This trial tests a new drug, NRT6020, that targets a protein called FAP found on many solid tumors. It aims to see if the drug is safe and how it works in people with advanced solid tumors that have not responded to other treatments.
ShanghaiAges 18–80 - NCT06905808Recruiting
Normal Bladder Pressure Values Using e-Sense Catheter
This study uses a special catheter to measure normal bladder pressures during a standard bladder test. It aims to find what normal pressure values are for different ages and genders.
BristolAges 20 years+ - NCT06306326Recruiting
Using 3D scanning to check fat grafting for facial defects
This study uses 3D face scanning to see how well your own fat, taken from another part of your body, can restore fullness to your face. It might help if you have a sunken or uneven look from a birth defect, injury, or aging.
Beijing, Beijing MunicipalityAges 3–80 - NCT05888428Recruiting
Test of a smart arm prosthesis control system for arm amputees
This trial studies whether the MyoTrain system can help people with a below-elbow (trans-radial) arm amputation control a myoelectric prosthesis using muscle signals. It may help you practice and use a more “thought-to-movement” style control method if you meet the safety and participation requirements.
Grand Rapids, MichiganAges 18 years+ - NCT06803602Enrolling by invitation
Magnetic therapy for urine leaks after prostate surgery
This trial tests a non-invasive magnetic treatment (HIFEM) to help men with urine leaks after prostate cancer removal (radical prostatectomy) or HoLEP surgery. The goal is to see if it improves bladder control and quality of life.
Scottsdale, ArizonaAges 18–100 - NCT06770972Recruiting
Parenting support for IVF and ART families
This study tests a virtual class for people who became pregnant through fertility treatments like IVF. The class aims to help you and your caregiving partner build a strong foundation for your family.
Los Angeles, CaliforniaAges 18 years+
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,128 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.